NVOon logo

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The...

NYSEHealthcareDrug Manufacturers - GeneralUSA

Company Profile

Stock Code
NVO
ISIN Code
US6701002056
Currency
US Dollar (USD)
IPO Date
1982-01-04

Contact Information

Company Address
Novo Alle 1, Bagsvaerd, Denmark, 2880
Contact Phone
45 44 44 88 88
Company Website
https://www.novonordisk.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Dividend Yield
4.07%
Return on Assets (TTM)
19.25%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99